Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

FDA Kills ISO Voluntary Audit Program As MDSAP Efforts Accelerate

This article was originally published in The Gray Sheet

Executive Summary

The agency has terminated a 2012-launched ISO 13485 voluntary audit program, which gave companies the chance for a one-year reprieve from an FDA inspection, to put all attention on the global Medical Device Single Audit Program.

Advertisement

Related Content

FDA Report: MDSAP Single-Audit Pilot Challenged By Device-Maker Recruitment
10 Things You Should Know About The Medical Device Single-Audit Pilot
FDA’s ISO Audit Program Chugs Along; May Be Absorbed By IMDRF Single-Audit Initiative

Topics

Advertisement
UsernamePublicRestriction

Register